June Off to a Poor ...
Health Care: Drugs
AVANIR Pharmaceuticals (AVNR: NASDAQ)
$2.82 -0.15 | -5.05%
06/01/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 41.40 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | n.a. | 12.50 |
| Beta | 2.08 | 0.46 | 0.98 |
| Price to Sales (TTM) | 15.65 | 2.04 | 1.42 |
| Price to Book (MRQ) | 6.45 | 2.63 | 2.41 |
| Price to Tangible Book (MRQ) | 6.45 | -21.74 | 5.08 |
| Price to Cash Flow (TTM) | -5.80 | 17.80 | 9.80 |
| Price to Free Cash Flow (TTM) | -6.20 | 38.30 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.60 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.30 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | n.a. | -0.76 |
| Payout Ratio (TTM) | 0.00 | 0.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 598.90 | 14.20 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 262.50 | 10.80 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | -1.19 | 19.65 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 116.90 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 116.90 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | 1.26 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | n.a. | -1.90 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 4.30 | 1.10 | 1.10 |
| Current Ratio (MRQ) | 4.40 | 1.80 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.69 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.81 | 0.96 |
| Interest Coverage (TTM) | n.a. | 2.80 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 97.60 | 49.40 | 46.90 |
| Gross Margin - 5 Yr Avg | 94.80 | 46.00 | 47.70 |
| EBITD Margin (TTM) | n.a. | 20.70 | 18.90 |
| EBITD - 5 Yr Avg | -315.36 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | n.a. | 7.40 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | n.a. | 0.50 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -2.74 | 0.06 | 0.09 |
| Net Profit Margin - 5 Yr Avg | n.a. | -1.70 | 7.00 |
| Return on Assets (TTM) | -84.50 | 3.20 | 3.10 |
| Return on Assets - 5 Yr Avg | -58.90 | -0.80 | 2.50 |
| Return on Investment (TTM) | -112.00 | 4.50 | 7.90 |
| Return on Investment - 5 Yr Avg | -88.40 | -1.10 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 130,033.00 | 609,034.00 | 449,376.00 |
| Net Income/Employee (TTM) | -356,608.00 | 36,701.00 | 39,003.00 |
| Receivable Turnover (TTM) | 7.00 | 4.70 | 7.60 |
| Inventory Turnover (TTM) | 1.10 | 2.70 | 8.30 |
| Asset Turnover (TTM) | 0.30 | 0.60 | 0.40 |
Portfolios with AVNR
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Most Shorted Stocks in B...
- Contributor5 Stocks Under-$10 Setting ...
- Contributor5 Biotech Drug-Launch Stock...
- ContributorBreakout Stocks Of The Week...
- UserMy Portfolio
- Contributor6 Heavily Shorted Stocks 04...
- Contributor5 Stocks With the Largest S...
- Usergm401
- Userparvardigar
Latest AVNR Headlines from TheStreet
- Avanir Pharmaceuticals CEO Presents At Bank Of America Merrill Lynch Health Care Conference (Transcript) 05.17.12 | 05:05 pm
- Avanir Pharmaceuticals' Presents At Deutsche Bank Securities Annual Health Care Conference (Transcript) 05.09.12 | 11:05 pm
- Avanir Pharmaceuticals' CEO Discusses F2Q2012 Results - Earnings Call Transcript 05.08.12 | 03:05 pm
- Avanir's CEO Presents At Citi 2012 Global Health Care Conference - Transcript 02.29.12 | 01:02 pm
- AVANIR Pharmaceuticals' CEO Discusses F1Q12 Results - Earnings Call Transcript 02.07.12 | 10:02 pm
- Friday's Top 10 Articles, Videos on TheStreet 01.20.12 | 02:01 pm
- Biotech Stock Mailbag: Celldex, Hep C Bubble, Al Mann Anger 01.20.12 | 05:01 am
- AVANIR Stock Hits New 52-Week Low (AVNR) 12.14.11 | 03:12 pm
- Avanir's CEO Discusses Q4 2011 Results - Earnings Call Transcript 12.12.11 | 11:12 pm
- Biotech Stock Mailbag: 2011 Report Card 11.25.11 | 05:11 am
Press Releases for AVNR
- Avanir Pharmaceuticals To Present At Jefferies 2012 Global Healthcare Conference - PR Newswire 05.29.12 | 08:05 am
- Avanir Pharmaceuticals To Present Data At The American Academy Of Neurology Annual Meeting - PR Newswire 04.17.12 | 08:04 am
- Avanir Pharmaceuticals To Present At BioCentury Future Leaders In The Biotech Industry Conference - PR Newswire 04.10.12 | 08:04 am
- Avanir Pharmaceuticals Announces Appointment Of Rohan Palekar As Chief Commercial Officer - PR Newswire 03.16.12 | 08:03 am
- Avanir Pharmaceuticals To Participate In Two Conferences In March - PR Newswire 03.01.12 | 04:03 pm
- Avanir Pharmaceuticals To Participate In Citi 2012 Global Health Care Conference - PR Newswire 02.21.12 | 09:02 am
- Avanir Pharmaceuticals Announces Publication Of Phase III Study Results Showing Efficacy And Safety Of AVP-923 In The Treatment Of Diabetic Neuropathic Pain - PR Newswire 02.08.12 | 09:02 am
- Avanir Pharmaceuticals Announces Date Of Fiscal 2012 First Quarter Financial Results And Conference Call - PR Newswire 01.30.12 | 08:01 am
- Avanir Pharmaceuticals Announces Date Of Fiscal 2011 Fourth Quarter And Year End Financial Results And Conference Call - PR Newswire 12.06.11 | 08:12 am
- Avanir Pharmaceuticals To Participate In Piper Jaffray Health Care Conference - PR Newswire 11.22.11 | 08:11 am
Partner Headlines for AVNR
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
- Avanir Pharmaceuticals: Limelight On The Horizon - Seeking Alpha 02.17.12 | 06:02 am
- Canaccord Reiterates Buy, $6 PT on Avanir Pharmaceuticals - Benzinga 11.30.11 | 09:11 am
- Avanir - Closing Short Position - Seeking Alpha 11.27.11 | 08:11 am
- 10 Small-Cap Stocks Deeply Undervalued By Target Price - Seeking Alpha 11.11.11 | 10:11 pm
- Avanir Pain Drug Should Provide Long-Term Growth - Seeking Alpha 09.30.11 | 06:09 pm
- Avanir: Congressional Inquiry Into the Pricing of Nuedexta Abandoned - Seeking Alpha 07.22.11 | 09:07 am
- Hearing Negative Chatter in Avanir Pharmaceuticals - Benzinga 06.30.11 | 01:06 pm
- Jefferies' Upadates - Benzinga 06.03.11 | 09:06 am
- Investors Should Take Notice of Congressional Questions Regarding Nuedexta Pricing - Seeking Alpha 05.27.11 | 09:05 am
